+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 60Years
All Genders
ID04544774

Evaluating Nasal Allergen Provocation Test for Starting and Monitoring Allergen Immunotherapy in Allergic Rhinitis Patients

Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2026-05-01

200

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with persistent or intermittent allergic rhinitis, including local allergic rhinitis, who are starting allergen immunotherapy AIT. The study aims to compile a database of all patients undergoing immunotherapy and to evaluate the cost and effectiveness of treatment using the Nasal Allergen Provocation Test NAPT. This observational study is conducted at two hospitals and focuses on patients confirmed by skin prick tests or immunocap for specific IgEs. Participants will undergo NAPT before, during, and after their AIT treatment, which targets airborne allergens such as house dust mite, trees, and grasses. The study involves four visits and two telephone contacts repeated annually for three years. The goal is to monitor the response to AIT and assess cost savings by targeting treatment to the allergen with the strongest response and by stopping treatment early in non-responders. During the study, patients will have blood tests measuring total and specific IgE levels, and their quality of life will be evaluated using several questionnaires including Lebel score, SNOT-22, VAS, TNSS, ACT, RQLQ, and TRE. Nasal airflow will be assessed by PNIF measurements. These assessments occur before AIT starts, every six months during treatment, and after three years. The study also tracks safety and treatment adherence throughout the participation period.

CONDITIONS

Brief Title

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

Research Team

M

Margot Vandekerckhove

L

Laura Van Gerven, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here